Neointimal hyperplasia is a common feature of fibro-proliferative vascular disease and characterizes initial stages of atherosclerosis. Neointimal lesions mainly comprise smooth muscle-like cells. The presence of these lesions is related to local differences in shear stress. Neointimal cells may arise through migration and proliferation of smooth muscle cells from the media. However, a role for the endothelium as a source of smooth muscle-like cells has largely been disregarded. Here, we investigated the role of endothelial-to-mesenchymal transition (EndMT) in neointimal hyperplasia and atherogenesis, and studied its modulation by shear stress.
Introduction
Neointimal hyperplasia is a common feature of fibro-proliferative vascular disease and characterizes initial stages of atherosclerosis, a multifactorial disease that primarily affects large-and medium-sized arteries. 1 Although most risk factors for atherosclerosis are present at the systemic level, the disease develops in predisposed, atheroprone regions. 2 These regions are characterized by disturbed flow, typically encountered at the outer walls of vascular bifurcations and at the inner wall of vascular curvatures. 3 Previous studies have identified anti-inflammatory and anti-coagulant effects of uniform laminar shear stress (LSS) on endothelial cells (EC). 2, 4 Besides, shear stress affects endothelial control of smooth muscle cell migration and proliferation. 5 We and others have previously shown that EC can acquire a fibro-proliferative mesenchymal phenotype through endothelial-to-mesenchymal transition (EndMT). 6 -9 This transition process is characterized by loss of cell-cell adhesions and changes in cell polarity. Endothelial cell markers, such as VEcadherin and PECAM-1 are reduced, while the expression of mesenchymal cell markers, such as a-smooth muscle actin (aSMA) and calponin are induced. 6, 8 Functionally, cells acquire myofibroblast-like characteristics with contractile function, enhanced migratory phenotype, and increased extracellular matrix production. 8 In the process, endothelial function, such as anti-thrombogenicity, is lost. 6, 8 EndMT was originally observed during embryogenesis where it plays a crucial role in cardiac valve formation. 10 In recent years, it has become clear that mesenchymal transition of EC is not restricted to embryonic development but also occurs in adult life, where it contributes to pulmonary vascular remodelling 11 and cardiac and kidney fibrosis. 12, 13 In addition, EndMT has been suggested to occur in neointimal thickening associated with transplant atherosclerosis and restenosis. 14, 15 The aims of this study were to elucidate whether EndMT contributes to neointimal hyperplasia and atherogenesis, and to decipher whether modulation of EndMT by fluid shear stress can explain the focal nature of fibro-proliferative vascular disease.
Methods

Clinical samples
Carotid plaques were obtained from six patients undergoing elective carotid endarterectomy for symptomatic high-grade stenosis of the internal carotid artery at the department of Vascular Surgery, UMCG. Samples were fixed in neutral buffered formalin prior to paraffin embedding. Patients gave informed consent and the investigation was performed according to institutional guidelines and the Declaration of Helsinki.
Animals and surgical procedures 2.2.1 Pigs
The investigation conforms to the recommendations in the 8th Edition of the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health (NRC 2011) and was approved by the local Ethical Committee. Porcine abdominal aortic trifurcations were obtained from healthy male Yorkshire pigs (12 -13 weeks of age; body weight 30 -35 kg, n ¼ 3) which were obtained from V.O.F. van Beek (Lelystad, the Netherlands). Animals were fed a normal diet. Animals were sacrificed under anaesthesia with ketamine (Nimatek) and midazolam with a bolus of pentobarbital and heparin (Actrapid).
Mice
The investigation conforms to the recommendations in the 8th Edition of the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health (NRC 2011) and was approved by the local Ethical Committee. Male C57Bl/6j wild-type mice (8 -12 weeks of age, n ¼ 8) were obtained from Harlan (Horst, the Netherlands). During the entire experiment, animals were kept on a 12 h light:12 h dark cycle with ad libitum access to standard laboratory chow and water. Aortic banding (n ¼ 5) was performed under anaesthesia [2% Isofluorane (Forene/Abbott, The Netherlands) and oxygen] and analgesia (Carprofen, 5 mg/kg), with body temperature and hydration control throughout surgery. Briefly, an incision was made in the second intercostal space. Next, a small incision was made in the parietal pleura, through which the ascending loop of the aorta was exposed. A suture was placed around the aorta. The aorta was supported with a 27G needle, and suture was drawn tight, after which the needle was removed. Thereafter, the pleura, muscle layers, and skin were closed by sutures. Animals received post-operative analgesia (Carprofen, 5 mg/kg/24 h for 48 h). In sham-operated animals (n ¼ 3), all procedures were performed except for the actual aortic banding. Animals were sacrificed under deep anaesthesia [3% Isofluorane (Forene/Abbott, The Netherlands] by exsanguination, 8 weeks after the procedure, after which the thoracic aorta was explanted.
Cell cultures
Human umbilical vein endothelial cells (HUVEC) and human aortic endothelial cells (HAEC) were purchased from Lonza Walkersville (MD, USA) or obtained from the endothelial cell facility, UMCG and cultured in endothelial cell medium (ECM) up to passage 5 as described previously (6 ; Harbor Bio-Products) six-well culture plates (Greiner Bio One, the Netherlands).
Plasmids, lentiviral, and retroviral transductions
A retroviral construct for stable expression of constitutively active rat MEK5-a1 (pBP-MEK5D) was generated as described before. 23 
Immunohistochemistry
Heat-induced epitope retrieval was performed with 0.1 M Tris-HCl (pH 9.0, 808C, overnight) on the formalin fixated, paraffin-embedded sections before proceeding with immunohistochemistry. Sections were incubated with primary antibodies at 48C overnight, followed by incubation with secondary antibodies at room temperature for 1 h. For calcium deposition, slides were incubated with Alizarin Red (Sigma-Aldrich, the Netherlands) at 20 mg mL 21 , pH 4.1. The list of antibodies and the used concentrations is provided in Supplementary material online, Table S1 . Detailed description of the imaging procedures is provided in the Supplementary material, Methods.
Immunoblotting
Whole cell lysates were prepared in RIPA buffer (Thermo Scientific, IL, USA) supplemented with 1% protease inhibitor cocktail and 1% phosphatase inhibitor cocktail (both Sigma-Aldrich). Protein concentrations were determined using Bio-Rad DC protein assay (Bio-Rad, VA, USA), according to manufacturer's protocol. Equal amounts were loaded on a 10% denaturing SDS -polyacrylamide gel, separated by gel electrophoresis and blotted onto nitrocellulose membrane (Hybond-P; Amersham Pharmacia Biotech, England, UK) according to standard protocols. Blots were blocked in Odyssey Blocking Buffer (Li-COR Biosciences, NE, USA) at room temperature for 1 h and incubated at 48C overnight with primary antibodies in Odyssey Blocking Buffer, supplemented with 0.1% Tween-20. Blots were incubated with secondary antibodies the next day. Protein was detected using the Odyssey Infrared Imaging System (Li-COR Biosciences). Densitometric analysis was performed using Totallab 120 (Nonlinear Dynamics, Newcastle upon Tyne, England). The list of employed antibodies and their concentrations is given in Supplementary material online, Table S2 .
Gene transcript analysis
RNA was isolated using TRIzol reagent (Invitrogen Corp, CA, USA) according to the manufacturer's protocol. cDNA synthesis was performed using RevertAid TM First Strand cDNA Synthesis Kit (Thermo Scientific, MA, USA), according to the manufacturer's protocol. The cDNA-equivalent of 5 ng RNA was used for amplification in 384-well microtitre plates in an ABI7900HT cycler (Applied Biosystems, CA, USA) using SYBR Green chemistry (Bio-Rad, VA, USA). Cycle threshold (C T ) values for individual reactions were determined using ABI Prism SDS 2.2 data processing software (Applied Biosystems) and normalized against b2M expression. All cDNA samples were amplified in duplicate. Relative expression was calculated using the DC T method. Data are presented as fold change compared with control, obtained using the DDCt method. The list of primers (Biolegio, The Netherlands) is enclosed as Supplementary material online, Table S3 .
Statistical analysis
Data are presented as means + s.e.m. n values relate to independent experiments. P-values were calculated using one-way analysis of variance followed by Bonferroni's post-hoc comparisons tests using Prism Graphpad (Graphpad Software, La Jolla, CA, USA). P , 0.05 was considered statistically significant.
Results
Human atherosclerotic plaques were analysed for co-expression of platelet endothelial cell adhesion molecule-1 (PECAM-1), and mesenchymal marker alpha-smooth-muscle actin (aSMA). Double-positive cells were detected, suggestive for cells in intermediate stages of EndMT, both in the inner lining as well as deeper in the neointimal tissue ( Figure 1A) . Given the focal nature of vascular disease, we next evaluated whether the presence of EndMT was related to local differences in shear stress profiles. Since complete transition results in loss of classical endothelial markers, the expression of endocan was analysed, an endothelial dermatan sulphate proteoglycan also known as endothelial specific molecule-1, which co-expresses with mesenchymal markers during embryonic EndMT. 16 We investigated regions exposed to uniform LSS and disturbed flow in the porcine abdominal aortic trifurcation ( Figure 1B and Supplementary material online, Figure S1 ). The outer walls of the trifurcation, characterized by disturbed flow, 17 showed pronounced neointimal thickening. Endocan-positive cells were detected throughout the neointima and co-expressed mesenchymal markers aSMA, transgelin, and calponin ( Figure 1B and Supplementary material online, Figure S1A ). In contrast, neointimal lesions were absent in areas exposed to uniform LSS, and endocan expression was confined to the endothelial monolayer (Supplementary material online, Figure S1B ). Since regions exposed to uniform LSS showed no evidence for the presence of myo-EC, suggesting protection from EndMT, the effect of EndMT is modulated by fluid shear stress uniform LSS was studied on EndMT in vitro. HUVEC were stimulated with transforming growth factor beta-1 (TGFb1), both under static conditions and with exposure to 20 dyne cm 22 of uniform LSS, comparable to the average level of shear stress found in large arteries. 18 Under static conditions, stimulation with TGFb1 resulted in hypertrophy and disruption of the monolayer, similar to earlier descriptions of embryonic EndMT 19 ( Figure 2A) . In contrast, when cells were stimulated with TGFb1 and concomitantly exposed to uniform LSS, they aligned to the flow direction, and retained a confluent monolayer (Figure 2A ). In the absence of uniform LSS, EndMT was induced, confirmed by the induction of mesenchymal markers on gene-transcript levels ( Figure 2B ) and protein expression levels ( Figure 2C ). Endothelial PECAM-1 expression levels were reduced on gene-transcript and protein-expression levels ( Figure 2B and C ). VE-Cadherin expression levels showed a similar trend but were not significantly changed, this is likely explained by the limited timeframe in which the experiments were performed, as waning of endothelial markers follows the induction of mesenchymal markers during the transition process. Cells exposed to uniform LSS maintained the endothelial phenotype and thus were resistant to EndMT ( Figure 2B and C ). To confirm that uniform LSS also inhibits EndMT of adult EC, HAEC were similarly stimulated with TGFb1, both under static conditions and with concomitant exposure to 20 dyne cm 22 of uniform LSS.
As expected, stimulation of HAEC with TGFb1 under static conditions induced EndMT, which was inhibited by uniform LSS (Supplementary material online, Figure S2A ). Next, we dissected the pathway responsible for inhibition of EndMT by uniform LSS. While all major MAPK pathways are involved in mechanotransduction of shear stress, a major role is accredited to the MEK5/ERK5 cascade 20 and many of the atheroprotective effects of uniform LSS have been attributed to this signalling cascade. 20 -22 In contrast to other MAPK signalling pathways, which showed transient activation upon exposure to uniform LSS (Supplementary material online, Figure S3 ), we found sustained activation of ERK5 in EC from 15 min up to at least 48 h of exposure to uniform LSS ( Figure 3) . Consequently, downstream effectors of ERK5, i.e. Krüppel-like factor 2 21 and 4 23 were induced, both on gene-transcript levels ( Figure 2B ) and TGFb1, both under static conditions (2) and with concomitant exposure to 20 dynes cm 22 of uniform LSS (+) for 24 and 48 h. n ¼ 3. P-values were calculated using one-way ANOVA followed by Bonferroni's post-hoc comparisons tests. *P , 0.05, **P , 0.01, and ***P , 0.001.
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protein-expression levels ( Figure 3) . HAEC showed similar induction of KLF2 and KLF4 gene-transcript levels after exposure to uniform LSS (Supplementary material online, Figure S2B ).To further explore the role for ERK5 signalling in EndMT inhibition, EC were transduced with a short hairpin construct directed against ERK5 (Figure 4 and Supplementary material online, Figure S4 ). ERK5 silencing caused spontaneous morphological changes suggestive for EndMT, which became more apparent with TGFb1 stimulation ( Figure 4A ). These observations were confirmed by the upregulation of mesenchymal markers transgelin and calponin, which was only partially inhibited by exposure to uniform LSS ( Figure 4B and C ). To establish the significance of ERK5 signalling in inhibition of EndMT, we expressed a constitutively active mutant of its MAP kinase MEK5 (MEK5D) in EC 23 ( Figure 5 and Supplementary material online, Figure S5 ). MEK5D-transduced EC were resistant to TGFb1-induced EndMT under static conditions, similar to non-transduced EC exposed to uniform LSS. EC transduced with MEK5D retained a confluent monolayer and showed no signs of hypertrophy ( Figure 5A ). Endothelial markers were retained and mesenchymal markers were not induced in MEK5D-transduced cells, both on gene-expression ( Figure 5B ) and protein-expression levels ( Figure 5C ). Similarly, HAEC transduced with MEK5D showed reduced transgelin and calponin gene-transcript levels after stimulation with TGFb1 compared with empty vector controls, whereas PECAM-1 gene transcript was increased in MEK5D-transduced HAEC (Supplementary material online, Figure S5A ). Since uniform LSS inhibits EndMT, we hypothesized that disturbed flow might have opposite effects. To study the differential effects of uniform LSS and disturbed flow on atherogenic differentiation, EC were exposed to LSS in Y-shaped channels which mimic the shear-stress gradients seen near arterial bifurcations. EC were protected from TGFb1-induced EndMT in areas of uniform LSS ( Figure 6A ). Cells exposed to disturbed flow, present at the bifurcations and at the outer curves, showed decreased expression of VE-Cadherin and increased expression of transgelin, indicative for EndMT ( Figure 6A and B) . Atherogenesis is characterized by increased extracellular matrix production and deposition. Collagens form the major component of plaques of which collagen type 1 is the most prevalent isotype. 24 Areas exposed to disturbed flow showed increased collagen I deposition ( Figure 6B ). In more advanced stages of atherosclerosis, lesions can progress to form fibro-calcific plaques containing calcifications. 25 As
EndMT can induce a stem cell-like phenotype with osteoblastic potential, 26 we studied if differential shear-stress profiles affect calcium deposition by EC cultured under osteogenic conditions. Indeed, calcium deposition was found in areas exposed to disturbed flow ( Figure 6B ). EC with constitutively active MEK5 were protected from EndMT, also in areas exposed to disturbed flow ( Figure 6C ), failed to produce significant amounts of collagen I and did not show any calcium deposition ( Figure 6C ). Thus, atherogenic differentiation can be triggered in EC exposed to disturbed flow, and ERK5 activation can inhibit this process. Finally, to gain additional evidence to support that disturbed flow can induce EndMT in vivo, mice were subjected to transverse thoracic-aortic constriction, resulting in a narrowed lumen with disturbed blood flow ( Figure 7A ). In the vicinity of the ligation, which is characterized by disturbed flow, the endothelial lining showed drastic remodelling with loss of the typical endothelial monolayer architecture ( Figure 7B ). EC overlaid each other and co-expressed PECAM-1 with mesenchymal markers aSMA, transgelin, and calponin, reminiscent of EndMT ( Figure 7B ). Sham-operated mice showed intact endothelial monolayers, negative for mesenchymal marker expression ( Figure 7C ).
Discussion
Our data suggest that EndMT occurs in fibro-proliferative vascular disease and that it contributes to neointimal hyperplasia and atherogenic differentiation of EC. Importantly, we uncovered that EndMT is modulated by shear stress in an ERK5-dependent manner. Thereby, we identified a novel atheroprotective mechanism of uniform LSS, which might in part further explain the focal nature of vascular disease. EndMT is modulated by fluid shear stress As proof-of-concept, we analysed human atherosclerotic plaques and porcine neointimal lesions for evidence of EndMT and identified myo-EC in intermediate stages of transition. 27 This corroborates earlier suggestions of a role for EndMT in neointimal thickening. 14, 15 This was recently confirmed by Cooley et al. 28 by using lineage tracing strategies to study the contribution of different cell types to the neointima formation during vein graft remodelling. They observed that 51.7 + 3.3% of the neointimal cells were of endothelial origin. 28 In addition,
Yao et al. 29 showed that EndMT contributes to vascular calcification.
Together, these data clearly indicate that EndMT contributes to vascular disease. In the human and porcine tissues we analysed, the presence of myo-EC was confined to regions with disturbed shear stress. To further substantiate a role for EndMT in neointimal hyperplasia and to study its relation to disturbed shear stress, we experimentally induced disturbed flow in the murine thoracic aorta using thoracicaortic constriction. While there was no evidence for EndMT in the sham-operated mice, myo-EC were present in the areas exposed to disturbed flow. Since these observations lack spatiotemporal resolution, we cannot rule out that the myo-EC arise through other mechanisms than EndMT. Earlier studies have shown the formation of a (pseudo)endothelium by smooth muscle cells after endothelial denudation, although these cells did not co-express endothelial markers. 30, 31 The porcine tissues used in this study were obtained from healthy, untreated animals and myo-EC were observed throughout the neointima, not only at the innermost lining. Likewise, the thoracic-aortic constriction procedure in mice does not result in endothelial denudation, and also here the neointimal cells co-expressed endothelial PECAM-1, making this explanation less likely. It is, however, well established that media-derived smooth muscle cells contribute to neointima formation. 1 In this regard, EndMT might not only provide neointimal cells, but also act on migration and proliferation of smooth muscle cells through enhanced paracrine signalling. 8 Recently, Qiao under static conditions (2) or with exposure to 20 dynes cm 22 of uniform LSS (+) for 48 h. n ¼ 3. P-values were calculated using one-way ANOVA followed by Bonferroni's post-hoc comparisons tests. * P , 0.05, **P , 0.01, and ***P , 0.001.
et al. 32 demonstrated that the neointimal cells in experimental pulmonary hypertension, are partially derived from the endothelial lineage. However, using a different experimental model for the same disease, Sheikh et al. 33 showed that pathological muscularization of distal arterioles mainly involves migration and proliferation of pre-existing smooth muscle cells. This suggests that the mechanisms underlying these processes are distinct, which is supported by the fact that medial hypertrophy precedes the development of neointimal lesions in pulmonary hypertension. 34 The origin of fibro-proliferative cells is presumably vessel dependent, and influenced by local differences in haemodynamic forces such as shear stress or cyclic strain, as well as other microenvironmental cues such as oxygen tension levels. Most likely, these processes are intertwined and additional lineage-tracing analyses are needed to address the spatiotemporal relationship between these cells and processes. Importantly, our data uncovered a novel atheroprotective mechanism of shear stress, namely ERK5-mediated inhibition of EndMT, which in part can explain the focal nature of fibro-proliferative vascular disease. High LSS resulted in activation of ERK5 and inhibition of EndMT and atherogenic differentiation. While these processes were induced by disturbed flow, this could be inhibited by activation of ERK5. Earlier studies have shown that LSS is associated with quiescent, antiinflammatory, and anti-thrombogenic endothelium, which is mainly accredited to activation of the MEK5/ERK5 cascade. 20 -22 As a Relative gene-expression levels of downstream effectors Krüppel-like factor 2 and 4 (KLF2 and KLF4) were also strongly increased. n ¼ 3.
P-values were calculated using one-way ANOVA followed by Bonferroni's post-hoc comparisons tests. *P , 0.05, **P , 0.01 and ***P , 0.001. plays a pivotal role in the regulation of smooth muscle plasticity by acting as a potent transcriptional repressor of SM differentiation. KLF4 supresses myocardin expression, a potent co-activator of serum response factor (SRF) 38 and prevents SRF/myocardin from associating with SM gene promoters. 39 Transcription of SM genes is also repressed by KLF4 through direct binding to transforming growth factor-b control elements (TCE) in promoter regions of SMC differentiation genes 40 and by inhibiting binding of Smad3 to Smad binding elements (SBE). 41 In epithelial-to-mesenchymal transition (EMT), which has been studied more extensively than EndMT, KLF4 inhibits transition through transcriptional activation of E-cadherin 42 and suppression of Snail, 43 a suppressor of E-Cadherin and important inducer of EMT. 44 Interestingly KLF4 also transcriptionally regulates VE-Cadherin. 45 Since KLF4 can inhibit EndMT via multiple mechanisms, the inhibitory effects of ERK5 signalling on EndMT are likely mediated through KLF4. However, recent data indicate that KLF2, not KLF4, inhibits the enhanced migration of EC associated with fibro-proliferative vascular disease.
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KLF2 and KLF4 might thus act in concert in the inhibition of EndMT, which should be addressed in future studies. Our findings suggest that inhibition of EndMT might provide a novel therapeutic strategy to treat fibro-proliferative vascular disease by suppressing neointimal hyperplasia and atherogenic differentiation. Selective ERK5 agonists are required to determine the efficacy of ERK5 activation in inhibition of EndMT in vivo. From a clinical perspective, re-differentiation of fibro-proliferative cells to EC is also highly relevant, as it potentially enforces regression of disease by restoring vascular Nuclei are stained with DAPI (blue). To assess calcium deposition (red), cells were cultured in osteogenic medium for 6 days and analysed by Alizarin Red staining. Scale bars: 5 mm, n ¼ 3.
homeostasis. Remarkably, although reversion of epithelial cells through a process termed mesenchymal-to-epithelial transition (MET) is well established, 47 reversal of EndMT has not been described as yet.
Recent data indicate that cardiac fibroblasts undergo mesenchymalto-endothelial transition to enhance neovascularization in the injured heart through enhanced p53 signalling. 48 Intriguingly, prolonged exposure of EC to LSS results in sustained activation of p53 and growth arrest. 49 Moreover, KLF4 physically interacts with p53 in synergistic activation of p21, indicating interaction between p53 and ERK5 signalling pathways. 50 Activation of ERK5 thus not only inhibits mesenchymal transition of EC, but might also be the key to reversal of the transition process, which would provide exciting new perspectives on the treatment of cardiovascular disease and cardiovascular regeneration and should be addressed in future studies.
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